These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27117590)

  • 41. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
    Roncarati R; Viviani Anselmi C; Losi MA; Papa L; Cavarretta E; Da Costa Martins P; Contaldi C; Saccani Jotti G; Franzone A; Galastri L; Latronico MV; Imbriaco M; Esposito G; De Windt L; Betocchi S; Condorelli G
    J Am Coll Cardiol; 2014 Mar; 63(9):920-7. PubMed ID: 24161319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA-let-7e in serum-derived exosomes inhibits the metastasis of non-small-cell lung cancer in a SUV39H2/LSD1/CDH1-dependent manner.
    Xu S; Zheng L; Kang L; Xu H; Gao L
    Cancer Gene Ther; 2021 Apr; 28(3-4):250-264. PubMed ID: 33299140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy.
    Ma W; Ma CN; Zhou NN; Li XD; Zhang YJ
    Sci Rep; 2016 Aug; 6():31651. PubMed ID: 27530148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer.
    Chaniad P; Trakunran K; Geater SL; Keeratichananont W; Thongsuksai P; Raungrut P
    PLoS One; 2020; 15(10):e0241593. PubMed ID: 33125430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma.
    Xue X; Wang C; Xue Z; Wen J; Han J; Ma X; Zang X; Deng H; Guo R; Asuquo IP; Qin C; Wang H; Gao Q; Liu S; Wang J
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):281-293. PubMed ID: 32073597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma.
    Han Z; Li Y; Zhang J; Guo C; Li Q; Zhang X; Lan Y; Gu W; Xing Z; Liang L; Li M; Mi S
    Int J Med Sci; 2020; 17(10):1428-1438. PubMed ID: 32624699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
    Zhang Y; Xu H
    J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
    Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.
    Wei T; Cheng S; Fu XN; Feng LJ
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32364222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.
    Sun Y; Hawkins PG; Bi N; Dess RT; Tewari M; Hearn JWD; Hayman JA; Kalemkerian GP; Lawrence TS; Ten Haken RK; Matuszak MM; Kong FM; Jolly S; Schipper MJ
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):107-114. PubMed ID: 29051037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab.
    Halvorsen AR; Sandhu V; Sprauten M; Flote VG; Kure EH; Brustugun OT; Helland Å
    Acta Oncol; 2018 Sep; 57(9):1225-1231. PubMed ID: 29683761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients.
    Szpechcinski A; Florczuk M; Duk K; Zdral A; Rudzinski S; Bryl M; Czyzewicz G; Rudzinski P; Kupis W; Wojda E; Giedronowicz D; Langfort R; Barinow-Wojewodzki A; Orlowski T; Chorostowska-Wynimko J
    Cell Mol Life Sci; 2019 Sep; 76(18):3641-3656. PubMed ID: 30953094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant expression profiles and bioinformatic analysis of CAF-derived exosomal miRNAs from three moderately differentiated supraglottic LSCC patients.
    Wu C; Wang M; Huang Q; Guo Y; Gong H; Hu C; Zhou L
    J Clin Lab Anal; 2022 Jan; 36(1):e24108. PubMed ID: 34788477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical Application of Plasma miR-34b-3p and miR-302a-5p in the Diagnosis of Non-small Cell Lung Cancer].
    Song Z; Zhang Z; Liu Y
    Zhongguo Fei Ai Za Zhi; 2019 Apr; 22(4):216-222. PubMed ID: 31014439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients.
    Jiang M; Zhang P; Hu G; Xiao Z; Xu F; Zhong T; Huang F; Kuang H; Zhang W
    Mol Cell Biochem; 2013 Nov; 383(1-2):67-75. PubMed ID: 23881177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
    Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.